Viatris to Buy Pacira BioSciences for $1.65 Billion

Date:




Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Miranda Lambert On A.I. Songwriting: ‘It’s Terrifying’

Miranda Lambert has been writing songs for more than...

Stocks Slip and Oil Jumps on Fresh Tanker Attack

Rising energy prices weighed U.S. stocks, which fell for...

Majority of people in Myanmar are living in poverty or at risk, UN report says

BANGKOK -- More than two in three people living...